Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.83M.
Overvalued
The company’s latest PE is -0.03, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 298.27K shares, increasing 25.57% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.03K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.97.